Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

3 Robinhood Stocks to Buy Right Now
3 Robinhood Stocks to Buy Right Now

Robinhood Markets (NASDAQ: HOOD) has changed the investing game with its easy-to-use app and commission-free trades, which pushed the rest of the industry to get rid of trading commissions.

While

Better Buy: Disney vs. Warner Bros. Discovery
Better Buy: Disney vs. Warner Bros. Discovery

Last year, streaming and entertainment companies were brought under the spotlight as economic headwinds dragged down shares of the industry's leaders. Companies such as Walt Disney (NYSE: DIS) and

Better Buy: AMD vs. AmazonPhoto, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
Better Buy: AMD vs. Amazon

The COVID-19 pandemic led to a boom in cloud computing as hybrid workstyles meant more companies had to take their businesses online. Meanwhile, recent advances in artificial intelligence (AI) have

What Happened to Tesla This Week
What Happened to Tesla This Week

In this week's video, I cover everything you need to know about news related to Tesla (NASDAQ: TSLA) during the week of March 20. Today's video will focus on Tesla's continued domination in Europe

This Cancer Drug Candidate Could Be a Hit for PfizerPhoto, wide shot, wide-angle lens,  Home decor store, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/1f534af1-8f1f-47f4-aa9f-66269ecafb79.png
This Cancer Drug Candidate Could Be a Hit for Pfizer

Late last month, the U.S. Food and Drug Administration (FDA) granted priority review to Pfizer's (NYSE: PFE) multiple myeloma (MM) drug candidate elranatamab. With a decision from the FDA expected

3 Reasons to Buy Nike Stock Right Now
3 Reasons to Buy Nike Stock Right Now

Nike (NYSE: NKE) crushed top- and bottom-line estimates in its fiscal third-quarter earnings report on Tuesday, but that wasn't enough to please the market.

Although the stock was initially trading

The Stories Behind WWE's Vince McMahon
The Stories Behind WWE's Vince McMahon

Abraham Josephine Riesman is the author of Ringmaster: Vince McMahon and the Unmaking of America.

Motley Fool producer Ricky Mulvey caught up with Riesman to discuss: 

To catch full episodes of all

Disney World's Top Rival Is Already Looking Forward to Halloween
Disney World's Top Rival Is Already Looking Forward to Halloween

Halloween is more than seven months away, but you can't blame Comcast's (NASDAQ: CMCSA) Universal theme parks for starting to talk up its most popular nighttime event. Universal Orlando began

How Is Ally Financial Holding Up, Given the Current State of the Banking Industry?Photo, wide shot, wide-angle lens,  Private equity firm, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Edward Burtynsky: https://img.theapi.app/temp/2b695cca-48cb-4195-802a-e3385fb90ec0.png
How Is Ally Financial Holding Up, Given the Current State of the Banking Industry?

Since the collapse of SVB Financial and Signature Bank, a lot of bank stocks have been sold off significantly. One of those is the large digital consumer bank and auto lender Ally Financial (NYSE:

A Bull Market Is Coming: 1 Excellent Growth Stock to Buy Now
A Bull Market Is Coming: 1 Excellent Growth Stock to Buy Now

It's hard to predict the future with certainty, but it's safe to make some assumptions about how things will unfold in the next five or 10 years. For instance, given the general historical

Can This New Drug Boost Pfizer's Stock?Photo, wide shot, wide-angle lens,  Supermarket, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.theapi.app/temp/12c4d93c-5c0e-4e39-8e32-e47404ce9d79.png
Can This New Drug Boost Pfizer's Stock?

Pfizer's (NYSE: PFE) nasal spray Zavzpret was given the green light by the Food and Drug Administration earlier this month to treat patients with acute migraine. The company expects that the

Could This Stock Become the Tesla of Its Industry?Photo, wide shot, wide-angle lens, soft focus,  Car rental company, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-Ew7cRec38UnlyYzs41FVEri5.png?st=2023-12-29T14%3A03%3A41Z&se=2023-12-29T16%3A03%3A41Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T15%3A03%3A25Z&ske=2023-12-30T15%3A03%3A25Z&sks=b&skv=2021-08-06&sig=vZPI3wL5I%2BC5Zknik6hYtwmYdTdsE1ct/DM1evRA8EI%3D
Could This Stock Become the Tesla of Its Industry?

Sometimes a company pioneers a brand-new technology, turning an industry on its head. Tesla did that to the automotive industry. After gas engines had been the standard for over a century, this

3 Stocks You Can Keep Forever
3 Stocks You Can Keep Forever

Forever stocks can help set you up for life. Consider this: If you had invested $5,000 in Apple in 1999, you'd have $2.54 million today. And that's just one example of how long-term, buy-and-hold

This Chart Shows Where Tesla Goes From HerePhoto, wide shot, wide-angle lens, soft focus,  Car rental company, sunset photo at golden hour, photo by Art Wolfe: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-Ew7cRec38UnlyYzs41FVEri5.png?st=2023-12-29T14%3A03%3A41Z&se=2023-12-29T16%3A03%3A41Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-12-29T15%3A03%3A25Z&ske=2023-12-30T15%3A03%3A25Z&sks=b&skv=2021-08-06&sig=vZPI3wL5I%2BC5Zknik6hYtwmYdTdsE1ct/DM1evRA8EI%3D
This Chart Shows Where Tesla Goes From Here

The electric vehicle (EV) sector went mainstream last year as new options entered the market in categories including cars, pickup trucks, and semi tractor trailers. And 2022 was an especially

Banking News and Stocks to WatchPhoto, wide shot, wide-angle lens,  Private equity firm, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/6a5872d8-cc25-46f8-b436-bf3db1953908.png
Banking News and Stocks to Watch

In this podcast, Motley Fool senior analyst Bill Mann discusses:

Plus, Motley Fool analysts Sanmeet Deo and Tim Beyers face off against one another with stocks they believe are a better buy right

Stock Split Watch: Is MercadoLibre Stock Next?
Stock Split Watch: Is MercadoLibre Stock Next?

Fewer things spark interest in a stock more than a stock split. Even though this is primarily a cosmetic action (because it doesn't do anything to affect the core value of a company), a lower stock

Waze Co-Founder Uri Levine on Entrepreneurship, Autonomous Vehicles, and ChatGPT
Waze Co-Founder Uri Levine on Entrepreneurship, Autonomous Vehicles, and ChatGPT

Uri Levine is the co-founder of Waze and the author of Fall in Love with the Problem, Not the Solution: A Handbook for Entrepreneurs.

Alex Friedman, a member of The Motley Fool's member success

More Tech Layoffs; Ongoing Bank DramaPhoto, wide shot, wide-angle lens,  Bank, sunset photo at golden hour, photo by Art Wolfe: https://img.theapi.app/temp/3aa597ca-f944-4a9b-bf8d-3071f3b5a5c9.png
More Tech Layoffs; Ongoing Bank Drama

In this podcast, Motley Fool senior analyst Jason Moser discusses:

In addition, Motley Fool producer Ricky Mulvey catches up with Jacob Goldstein, host of the podcast What's Your Problem?, to talk

Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?Photo, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
Could This Label Expansion Be a Growth Catalyst for Sanofi Stock?

Recently, Sanofi (NASDAQ: SNY) and Regeneron (NASDAQ: REGN) received positive news from the U.S. Food and Drug Administration (FDA). The agency accepted Dupixent's supplemental Biologics License

AMD's 2023 Outlook: What to ExpectPhoto, wide shot, wide-angle lens,  Cloud computing provider, sunset photo at golden hour, photo by Thomas Heaton: https://img.theapi.app/temp/8d7b6619-8b3b-4e9e-b659-68643d72528e.png
AMD's 2023 Outlook: What to Expect

Let's chill out where Wall Street runs through Silicon Valley for a bit. Advanced Micro Devices (NASDAQ: AMD) is a leading semiconductor designer, specializing in PC-compatible x86 processors and

A Bull Market Is Coming: Is Coca-Cola Stock a Buy?Photo, wide shot, wide-angle lens,  Brewery, Midday, harsh overhead sunlight, directional sunlightt, photo by Peter Lik: https://img.theapi.app/temp/0cebecb6-c4f6-4c6e-b73e-f375daba8100.png
A Bull Market Is Coming: Is Coca-Cola Stock a Buy?

Concerns about the banking system and a potential recession have given the market shades of 2008. Investors are uneasy and looking for the best investments to park their money.

Beverage giant

If You Invested $10,000 in Virgin Galactic When It Went Public, This Is How Much You Would Have Today
If You Invested $10,000 in Virgin Galactic When It Went Public, This Is How Much You Would Have Today

The stock market tends to be rational over longer periods of time, but can be shockingly irrational over short periods. That's the big-picture story behind Virgin Galactic (NYSE: SPCE). It's worth

3 High-Yield Tech Stocks to Buy In March
3 High-Yield Tech Stocks to Buy In March

High dividend yields can be a sign that the market's not confident a company can afford its dividend. This is sometimes called a yield trap. But just like most things in life, there are exceptions

There's More to the Mint Mobile Deal Than Ryan Reynolds
There's More to the Mint Mobile Deal Than Ryan Reynolds

In this podcast, Motley Fool Senior Analyst Tim Beyers discusses:

Motley Fool analysts Kirsten Guerra and Jason Moser face off to make the case on why their chosen stock is a better buy right now.

These 2 Hot Stocks Could Rise By at Least 147% This Year, Per Wall Street
These 2 Hot Stocks Could Rise By at Least 147% This Year, Per Wall Street

Wall Street analysts often have some pretty outrageous predictions about where the prices of growth stocks are going, and 2023 is no exception. But even if their estimates are sometimes off by a